Sponsored

Sponsored Content by Pfizer

This content was funded by AstraZeneca and is intended for US healthcare professionals only.

Explore Tempus' latest advancements in artificial intelligence and how it is being applied in real-world oncology settings with Dr. Sanjay Juneja of Tempus and Dr. Debra Patt of Texas Oncology.

In extensive-stage small cell lung cancer, maintenance therapy is under investigation as a strategy to help delay progression, an area of critical importance in an aggressive, relapsing disease.

Scientists at Fox Chase Cancer Center have identified a mutation in a common oncogene that may play an important role in colon cancer.

Sponsored content by Castle Biosciences, Inc. Dr. Guenther has not been compensated in connection with this article; Dr. Guenther receives compensation for his participation on the Speaker’s bureau for Castle Biosciences.

Sponsored Content by Pfizer, Inc.

This is a featured episode from an educational podcast series with expert discussions on antibody drug conjugates, intended for US healthcare professionals.

Author(s): Sponsored by Novartis

Sponsored Content: Benjamin H. Lowentritt, MD, FACS reviews Real-World Head-to-Head Analyses Comparing Different Treatment Options For metastatic Castration-Sensitive Prostate Cancer

The study alters the existing paradigm that CDK1-Cyclin B1 is the only CDK-cyclin complex essential for all stages of mitosis.

Systematic identification of minor histocompatibility antigens informs outcomes after allogeneic stem cell transplantation.